Jacob Vincent Micallef - Aug 3, 2023 Form 4 Insider Report for VOLITIONRX LTD (VNRX)

Role
Chief Scientific Officer
Signature
/s/ Jacob Vincent Micallef
Stock symbol
VNRX
Transactions as of
Aug 3, 2023
Transactions value $
-$7,055
Form type
4
Date filed
8/7/2023, 04:05 PM
Previous filing
Jul 7, 2023
Next filing
Aug 28, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VNRX Common Stock Tax liability -$7.06K -5.43K -2.46% $1.30 215K Aug 3, 2023 Direct F1
holding VNRX Common Stock 35K Aug 3, 2023 By Spouse
holding VNRX Common Stock 38.1K Aug 3, 2023 By Borlaug Limited F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the aggregate number of shares of common stock retained by VolitionRx for cancellation to satisfy the tax withholding obligations of the reporting person upon settlement of 12,062 restricted stock units. No shares were sold by the reporting person or VolitionRx in such transaction.
F2 The shares of common stock are held directly by Borlaug Limited. The reporting person is a controlling director of Borlaug Limited and has voting and dispositive control over the shares of common stock held by Borlaug Limited.